<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>To elucidate the role of GNAS mutations in colorectal <z:e sem="disease" ids="C1326912" disease_type="Neoplastic Process" abbrv="">tumourigenesis</z:e>, we performed a mutation analysis in a total of 234 colorectal <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e>, including <z:mpath ids='MPATH_270'>adenomas</z:mpath>, serrated lesions and <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>Activating GNAS mutations were found in 20 of the 24 villous <z:mpath ids='MPATH_270'>adenomas</z:mpath> (83%) but were absent in <z:hpo ids='HP_0000001'>all</z:hpo> the other <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e>, except for one tubulovillous <z:mpath ids='MPATH_270'>adenoma</z:mpath> (3%) and two <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> (3%) </plain></SENT>
<SENT sid="2" pm="."><plain>KRAS and BRAF mutations were always mutually exclusive </plain></SENT>
<SENT sid="3" pm="."><plain>KRAS mutations were frequent in villous (67%) and tubulovillous (60%) <z:mpath ids='MPATH_270'>adenomas</z:mpath> but were rare or absent in tubular <z:mpath ids='MPATH_270'>adenomas</z:mpath> (6%) and serrated lesions, including <z:mpath ids='MPATH_140'>hyperplastic polyps</z:mpath>, sessile serrated <z:mpath ids='MPATH_491'>polyps</z:mpath>/sessile serrated lesions and traditional serrated <z:mpath ids='MPATH_270'>adenomas</z:mpath> (0-9%) </plain></SENT>
<SENT sid="4" pm="."><plain>BRAF mutations were found in four villous <z:mpath ids='MPATH_270'>adenomas</z:mpath> (17%) and in the large majority of serrated lesions (81-92%), but were absent in tubular and tubulovillous <z:mpath ids='MPATH_270'>adenomas</z:mpath> </plain></SENT>
<SENT sid="5" pm="."><plain>Seventeen villous <z:mpath ids='MPATH_270'>adenomas</z:mpath> (71%) harboured GNAS mutations concomitantly with KRAS or BRAF mutations </plain></SENT>
<SENT sid="6" pm="."><plain>Immunohistochemically, <z:hpo ids='HP_0000001'>all</z:hpo> the villous <z:mpath ids='MPATH_270'>adenomas</z:mpath> retained mismatch repair protein expression, suggesting that they are microsatellite-stable </plain></SENT>
<SENT sid="7" pm="."><plain>The current study showed that the presence of activating GNAS mutations, in association with KRAS or BRAF mutations, is a characteristic genetic feature of colorectal villous <z:mpath ids='MPATH_270'>adenoma</z:mpath> </plain></SENT>
</text></document>